Stephen D. Griffin - 03 Jun 2024 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, CFO and Treasurer
Signature
/s/ Stephen D. Griffin
Issuer symbol
ANIK
Transactions as of
03 Jun 2024
Net transactions value
$0
Form type
4
Filing time
05 Jun 2024, 16:10:59 UTC
Previous filing
02 Apr 2024
Next filing
18 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Award $0 +38,520 $0.000000 38,520 03 Jun 2024 Common Stock 38,520 $0.000000 Direct F1
transaction ANIK Stock Option (Right to Buy) Award $0 +96,525 $0.000000 96,525 03 Jun 2024 Common Stock 96,525 $29.35 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.
F2 Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
F3 The premium priced stock options vest in three equal annual installments beginning on June 3, 2025.